Patent granted in Israel

Adrian Harel (adrian.harelmedicortex.fi), Dec 9^th 2021

One of Medicortex´s patents, “Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage”, was granted in Israel (IL patent number 254980). The patent is pivotal in protecting the use of the novel newly discovered biomarker in TBI diagnostics.

Read the press release here.